Harrow Inc (HROW)
11.60
+1.31
(+12.73%)
USD |
NASDAQ |
May 10, 16:00
11.60
0.00 (0.00%)
After-Hours: 20:00
Harrow Net Income (TTM): -24.41M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.41M |
| September 30, 2023 | -14.21M |
| June 30, 2023 | -16.28M |
| March 31, 2023 | -18.29M |
| December 31, 2022 | -14.09M |
| September 30, 2022 | -22.56M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -20.66M |
| December 31, 2021 | -18.01M |
| September 30, 2021 | -9.44M |
| June 30, 2021 | 7.526M |
| March 31, 2021 | 9.767M |
| December 31, 2020 | -3.357M |
| September 30, 2020 | -1.849M |
| June 30, 2020 | -21.96M |
| March 31, 2020 | -24.10M |
| December 31, 2019 | 0.168M |
| September 30, 2019 | 15.64M |
| June 30, 2019 | 24.60M |
| March 31, 2019 | 29.50M |
| December 31, 2018 | 14.62M |
| September 30, 2018 | -6.276M |
| June 30, 2018 | -9.454M |
| March 31, 2018 | -10.49M |
| December 31, 2017 | -11.98M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.32M |
| June 30, 2017 | -13.47M |
| March 31, 2017 | -19.60M |
| December 31, 2016 | -19.09M |
| September 30, 2016 | -18.11M |
| June 30, 2016 | -18.21M |
| March 31, 2016 | -17.30M |
| December 31, 2015 | -15.90M |
| September 30, 2015 | -13.52M |
| June 30, 2015 | -12.02M |
| March 31, 2015 | -10.89M |
| December 31, 2014 | -10.12M |
| September 30, 2014 | -9.255M |
| June 30, 2014 | -8.881M |
| March 31, 2014 | -8.503M |
| December 31, 2013 | -7.643M |
| September 30, 2013 | -7.214M |
| June 30, 2013 | -6.382M |
| March 31, 2013 | -5.470M |
| December 31, 2012 | -5.384M |
| September 30, 2012 | -4.202M |
| June 30, 2012 | -3.042M |
| March 31, 2012 | -1.901M |
| December 31, 2011 | -0.9539M |
| September 30, 2011 | -1.108M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-24.42M
Minimum
Jun 2022
24.60M
Maximum
Jun 2019
-9.259M
Average
-14.21M
Median
Sep 2023
Net Income (TTM) Benchmarks
| Aquestive Therapeutics Inc | -28.77M |
| Cyclacel Pharmaceuticals Inc | -22.56M |
| Lifecore Biomedical Inc | -100.12M |
| Relmada Therapeutics Inc | -98.79M |
| Corvus Pharmaceuticals Inc | -24.86M |